A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients
Abroad (travel likely)Recruiting
Conditions
Familial Mediterranean Fever · Still Disease · Systemic Juvenile Idiopathic Arthritis · Adult-Onset Still Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Novartis, Basel, Switzerland
Study leads
Novartis Pharmaceuticals
Study Director
Novartis Pharmaceuticals